ICLR
NASDAQ · Life Sciences Tools & Services
Icon Plc
$169.55
+5.44 (+3.31%)
Financial Highlights (FY 2026)
Revenue
8.47B
Net Income
235.47M
Gross Margin
26.4%
Profit Margin
2.8%
Rev Growth
+2.2%
D/E Ratio
0.37
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 26.4% | 26.4% | 48.1% | 48.1% |
| Operating Margin | 5.4% | 4.8% | 10.5% | 12.7% |
| Profit Margin | 2.8% | 2.6% | 7.4% | 7.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 8.47B | 8.29B | 3.35B | 2.67B |
| Gross Profit | 2.24B | 2.19B | 1.61B | 1.29B |
| Operating Income | 454.94M | 400.82M | 353.31M | 338.76M |
| Net Income | 235.47M | 207.46M | 247.00M | 186.41M |
| Gross Margin | 26.4% | 26.4% | 48.1% | 48.1% |
| Operating Margin | 5.4% | 4.8% | 10.5% | 12.7% |
| Profit Margin | 2.8% | 2.6% | 7.4% | 7.0% |
| Rev Growth | +2.2% | +2.2% | -1.3% | +12.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.80B | 1.80B | 6.18B | 4.84B |
| Total Equity | 4.86B | 4.86B | 4.58B | 4.76B |
| D/E Ratio | 0.37 | 0.37 | 1.35 | 1.02 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 847.91M | 788.56M | 599.26M | 448.41M |
| Free Cash Flow | — | — | 348.15M | 219.69M |